Denali Therapeutics Inc. (DNLI)
NASDAQ·Healthcare·Biotechnology
$19.96
+0.10%
Mkt Cap $3.15B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $3.08M | — | — | -$0.75 | -$0.73 | +2.67% | — | — |
| Q4 2025 Nov 6, 2025 | $2.86M | — | — | -$0.76 | -$0.74 | +2.63% | — | — |
| Q3 2025 Aug 11, 2025 | $5.64M | — | — | -$0.74 | -$0.72 | +2.70% | — | — |
| Q2 2025 May 6, 2025 | $2.97M | — | — | -$0.71 | -$0.78 | -9.86% | — | — |
| Q1 2025 Feb 27, 2025 | $12.75M | — | — | -$0.75 | -$0.67 | +10.67% | — | — |
| Q4 2024 Nov 6, 2024 | $11.62M | — | — | -$0.60 | -$0.63 | -5.00% | — | — |
| Q3 2024 Aug 1, 2024 | $12.51M | — | — | -$0.68 | -$0.59 | +13.24% | — | — |
| Q2 2024 May 7, 2024 | $14.02M | — | — | -$0.67 | -$0.68 | -1.49% | — | — |
| Q1 2024 Feb 27, 2024 | $8.36M | $305.04M | +3548.84% | -$0.82 | -$0.86 | -4.88% | — | — |
| Q4 2023 Nov 7, 2023 | $8.94M | $1.27M | -85.83% | -$0.83 | -$0.72 | +13.25% | — | — |
| Q3 2023 Aug 8, 2023 | $13.46M | $294.12M | +2085.16% | -$0.68 | $1.30 | +291.18% | — | — |
| Q2 2023 May 8, 2023 | $28.72M | $35.14M | +22.34% | -$0.71 | -$0.80 | -12.68% | — | — |
| Q1 2023 Feb 27, 2023 | $13.12M | $10.28M | -21.60% | -$0.78 | -$0.75 | +3.85% | — | — |
| Q4 2022 Nov 3, 2022 | $17.02M | $3.56M | -79.09% | -$0.83 | -$0.84 | -1.20% | — | — |
| Q3 2022 Aug 8, 2022 | $44.66M | $52.48M | +17.52% | -$0.52 | -$0.48 | +7.69% | — | — |
| Q2 2022 May 5, 2022 | $33.36M | $42.14M | +26.32% | -$0.47 | -$0.53 | -12.77% | — | — |
| Q1 2022 Feb 28, 2022 | $44.82M | $12.51M | -72.08% | -$0.41 | -$0.62 | -51.22% | — | — |
| Q4 2021 Nov 4, 2021 | $32.03M | $5.29M | -83.50% | -$0.51 | -$0.69 | -35.29% | — | — |
| Q3 2021 Aug 4, 2021 | $22.94M | $22.94M | +0.00% | -$0.37 | -$0.50 | -35.14% | — | — |
| Q2 2021 May 3, 2021 | $5.77M | $7.92M | +37.37% | -$0.37 | -$0.58 | -56.76% | — | — |